Washington Post: July 24, 2019. Allergan finally recalled their biocell textured breast implants because of the evidence that they can cause cancer. We thank the FDA for urging the company to recall these implants and we hope that the delay hasn’t harmed many patients.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Allergan Recalls Textured Breast Implant Tied to Rare Cancer
ABC Action News: July 24, 2019. NCHR president points out that the removal of Allergan biocell textured breast implants was inevitable because patients had died from lymphoma caused by the implants. Why weren’t they recalled sooner?
Read More »How Can You Tell Which Condom Works Better?
The Daily Beast: July 16, 2019. Which condoms are most effective at preventing pregnancy or STIs? We explain why nobody knows the answer.
Read More »FDA Releases Millions of Records of Incidents Involving Medical Devices
Joe Carlson and Jim Spencer, Star Tribune; June 21, 2019 The U.S. Food and Drug Administration on Friday published millions of previously undisclosed reports of problems and post-surgical complications involving medical devices, including reports on implantable cardiac defibrillators, pacemaker electrodes and dental implants. The roughly 6 million reports released Friday cover a wide array of devices in […]
Read More »FDA approves new female Viagra despite skepticism
Washington Post: June 21, 2019. The Food and Drug Administration on Friday approved sales of a new drug intended to enhance sexual desire in women.
Marketed as Vyleesi, also known as bremelanotide, the medication is a shot that comes in a push pen device, but it isn’t much more effective than placebo. And is it safe?